Get started
Author

Nils Schärer

Observed names: N., Schärer, Nania Schärer, Nils Schaerer
ORCID: 0009-0002-7218-1659
Observed ORCID: 0009-0002-7218-1659
OpenAlex ID: A5093368518
Detection of elusive DNA copy-number variations in hereditary disease and cancer through the use of noncoding and off-target sequencing reads
2024 · Mathieu Quinodoz, Karolina Kaminska, et al. · The American Journal of Human Genetics · 15
PDF
Evaluating the Progression of Retinal Sensitivity Loss in Geographic Atrophy Using Machine-Learning-Based Structure-Function Correlation (OMEGA 2)
2025 · Georg Ansari, Nils Schärer, et al. · Investigative Ophthalmology & Visual Science · 7
PDF
The Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients with Geographic Atrophy (OMEGA) Study: Design and Baseline Characteristics – OMEGA Report 1
2023 · Georg Ansari, Nils Schärer, et al. · Ophthalmic Research · 4
One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report
2025 · Anne Tillmann, Richard Stillenmunkes, et al. · Ophthalmology and Therapy · 3
PDF
Copeptin kinetics in healthy aging
2026 · Sven Lustenberger, Friederike Riehle, et al. · The Journal of Clinical Endocrinology & Metabolism · 1
The optical coherence tomography and microperimetry biomarker evaluation in patients with geographic atrophy ( OMEGA ) study: Geographic atrophy progression in fundus autofluorescence ‐ OMEGA report 3
2026 · Philippe Valmaggia, Georg Ansari, et al. · Acta Ophthalmologica · 1
Correction: One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report
2026 · Anne Tillmann, Richard Stillenmunkes, et al. · Ophthalmology and Therapy
PDF
MON-042 Intravenous [pyr1]apelin-13 Increases Sodium Levels In Healthy Volunteers With Artificially Induced Syndrome Of Inappropriate Antidiuresis
2025 · Sven Lustenberger, Sophie Monnerat, et al. · Journal of the Endocrine Society
PDF
Supplementary Material for: The Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients with Geographic Atrophy (OMEGA) Study: Design and Baseline Characteristics (OMEGA report 1)
2023 · G., Ansari, N., Schärer, et al. · Figshare
Supplementary Material for: The Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients with Geographic Atrophy (OMEGA) Study: Design and Baseline Characteristics (OMEGA report 1)
2023 · G., Ansari, N., Schärer, et al. · Figshare
Works count: 10
Citation count: 31
H-index: 3
I10-index: 1
Year
Topic
Type